Sure...they can skate thru like Amarin with their single phase-3 Marine trial and an SPA agreement with the FDA :) Of course nothing, particularly a Ph3 trial, is that easy, so skate might have been a poor choice of words. On the other hand...we're talking fish oil dude -- nothing earth-shattering or highly innovative, as opposed to many other drugs that have gone all the way.
Considering they invoked the 505(b)(2) NDA pathway, they were able to save time and money. Hopefully, they can do the same with Ph3 (save time and money, like Amarin).
Speaking of money, I would fully expect them to do a raise at some point in the near future. They are also 48% owned by NEPT, a large krill producer, so they can make things happen at that end also.
By all means, though, short it, I'm sure at some point it will be a good idea. I'm not in love with the stock(s), so I'm ready to pull the trigger in stages should things work my way. I am, however, a believer in good fish oil...NKO extract to be exact.
Messages posted by individuals may be misleading, deceptive, or in error. If you disagree with a posting, feel free to voice your opinion. It is the policy of iHub to allow our members to freely discuss issues in a free and open manner
